Primo Biotechnology

Primo is a radiopharmaceutical company based in Taiwan. In order to facilitate precision healthcare with molecular imaging in Taiwan, Primo was founded by Prof. Ya-Yao Huang and Dr. Joe Yeh in 2021 with many-year radiopharmaceutical discovery/development experience in Taiwan, especially about clinical introduction and IND submission of new radiopharmaceuticals. For several years now, our company has been focused on the one-stop clinical development of radiotheranostics in Taiwan, especially form pre-clinical studies, clinical network and regulatory filling to manufacturing , commercialization and distribution activities in Taiwan

Primo biotechnology operates in the Pharmaceutical manufacturing industry.

Primo biotechnology's revenue is 11m - 100m

Primo biotechnology has 11 - 50 employees.